資料詳細

  • 1 件中、 1 件目

[ 洋図書 ] Poor quality pharmaceuticals in global public health / ( Trust. Interdisciplinary perspectives, volume 5 )

Satoru Kimura, Yasuhide Nakamura. -- Springer, -- [2020], --

所蔵

所蔵は 1 件です。

所蔵館 所蔵場所 資料区分 請求記号 資料コード 所蔵状態 資料の利用
配架日 協力貸出 利用状況 返却予定日 資料取扱 予約数 付録注記 備考
中央 1F医療 一般洋図書 F/499.0/K49/P 7113519414 配架図 Digital BookShelf
2021/04/20 可能 利用可   0

Eメールによる郵送複写申込みは、「東京都在住」の登録利用者の方が対象です。

    • 統合検索
      都内図書館の所蔵を
      横断検索します。       類似資料 AI Shelf
      この資料に類似した資料を
      AIが紹介します。

ページの先頭へ

資料詳細 閉じる

ISBN 9811520887 (hardcover)
ISBN13桁 9789811520884 (hardcover)
無効なISBN等 9789811520891 (eBook)
テキストの言語 英語                  
分類：NDC10版 499.09
個人著者標目 Kimura, Satoru.
本タイトル Poor quality pharmaceuticals in global public health /
著者名 Satoru Kimura, Yasuhide Nakamura.
出版地・頒布地 Singapore :
出版者・頒布者名 Springer,
出版年・頒布年 [2020],
数量 xxiii, 216 pages :
他の形態的事項 illustrations (chiefly color) ;
大きさ 25 cm.
書誌注記 Includes bibliographical references.
要約、抄録、注釈等 This book aims to clarify the global aspects of poor quality pharmaceuticals, generic products in particular, becoming complicated through the process of IMPACT (International Medical Products Anti-Counterfeiting Taskforce) organized by the initiative of the World Health Organization (WHO) in 2006. The findings from this book provide a long-term perspective to policymakers. This book discusses from the following points: industrial standardization, healthcare market accessibility, motivation on supply side, WHO medicines policy and intellectual property rights. Standardization regulates the quality and enabled the generic medicines spreading to developing/emerging countries through technology transfer. However, quality is a part of cost and reflected to price. When a healthcare service market is divided according to wealth gap, compliance to standardization for quality on supply side is divided accordingly. Thus, poor quality pharmaceuticals are prevalent worldwide. Generic pharmaceuticals are essential resources in public health. The WHO has been involved in the dispute around the intellectual property rights under its intention to promote the new drug development for neglected diseases. Global pandemic of AIDs is a critical factor to accelerate the confusion. This created feelings of distrust among developing/emerging countries against developed countries if the WHO was in favour of developed countries. In addition to that, an easy and optimistic start of IMPACT stirred up conflicts of interests in the international community. The problem of poor quality pharmaceuticals became more complicated through the conflicts on intellectual property rights; patented drugs to generic drugs. A key for quality generic products is the formation of a single healthcare service market where good motivation on supply side together with fair competitiveness with patented pharmaceuticals and equitable access to services (both for the rich and the poor) are ensured. Political commitment to investment and regulatory infrastructure for the market is crucial.
著者標目 中村, 安秀, 1952-
シリーズ名・巻次 Trust. Interdisciplinary perspectives, volume 5
一般件名 Drugs -- Quality control.
Pharmaceutical chemistry.
資料情報1 『Poor quality pharmaceuticals in global public health /』（Trust. Interdisciplinary perspectives, volume 5）　Satoru Kimura, Yasuhide Nakamura.　Springer,　[2020], （所蔵館：中央　 請求記号：F/499.0/K49/P　 資料コード：7113519414）
URL https://catalog.library.metro.tokyo.lg.jp/winj/opac/switch-detail.do?lang=ja&bibid=1352046214

ページの先頭へ